University of Kentucky and The Markey Cancer Center
800 Rose Street, Pavilion CC
Lexington, KY 40536

A cancer diagnosis is a life-changing event filled with stress and anxiety. The UK Markey Cancer Centers understands the challenges you and your family face, and we’re here to help. Every day, patients turn to Markey to find answers to difficult problems and guidance in the face of uncertainty.

With the backing of world-class treatment and research, our cancer specialists will develop a treatment plan specialized for you with the ultimate goal of returning you to your life as quickly as possible.




Testimonials of Patients Treated with Cytoreductive Surgery and HIPEC by Dr. Joseph Kim

"My doctors in Spain told me there was no treatment for my cancer."
"HIPEC worked for me, and if it is a possibility for others, I think they should see if it will
Mr. Brian D is a 48-year-old Suffolk County Police Officer and father of five. He has let his hair grow
"After my treatment at Stony Brook, I had a CT scan that showed no sign of cancer."
“I just can’t speak highly enough about Dr. Kim. I absolutely love him and his staff, and my wife says

Cytoreductive Surgery and Hypothermic Intraperitoneal Chemotherapy for Mucinous Tumors of the Gastrointestinal Tract – Joseph Kim, MD

Professor and Chief of Surgical Oncology, Department of Surgery, University of Kentucky, Lexington, KY Abstract The peritoneal cavity is the largest potential space in the body. With its own lymphatic system and vascularization, it is critical to appreciate the biology of the peritoneum to better understand how disease may spread. For example, benign or low-grade malignancies may spread along the peritoneal surface by exploiting the lymphatic flow patterns of peritoneal fluid. Any pathological process involving the peritoneal cavity can easily disseminate throughout this space by means of unrestricted movement of fluid and cells. These varied mechanisms of disease spread necessitate…

Read More

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

Hyperthermic intraperitoneal chemotherapy (HIPEC) in conjunction with cytoreductive surgery (CRS) holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface, effectively targeting remaining microscopic residual tumor. HIPEC increases concentrations of chemotherapy directly within the peritoneal cavity compared with the intravenous route and reduces the systemic side effects associated with prolonged adjuvant intraperitoneal exposure…

Read More